Nasdaq · Technology
ULTRALIFE CORP (ULBI)
As-reported financials and recent SEC filings for ULTRALIFE CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$191.2M
Net income
$-5.9M
Net margin
-3.1%
Diluted EPS
$-35.00
ROE
-4.5%
P/E (TTM)
—
Market cap
—
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $191.2M | $164.5M | $158.6M | $131.8M | $98.3M |
| Gross profit | $46.0M | $42.3M | $39.2M | $29.4M | $24.6M |
| Operating income | $-5.9M | $10.0M | $9.5M | $129,000 | $35,000 |
| Net income | $-5.9M | $6.3M | $7.2M | $-119,000 | $-234,000 |
| Diluted EPS | $-35.00 | $38.00 | $0.44 | $0.05 | $0.05 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
DEFA14A2026-06-02
View on EDGAR →DEF 14A2026-06-02
View on EDGAR →SD2026-06-01
View on EDGAR →42026-05-26
View on EDGAR →42026-05-18
View on EDGAR →10-Q2026-05-08
View on EDGAR →8-K2026-05-08
View on EDGAR →10-K/A2026-04-29
View on EDGAR →Largest Technology peers
Go deeper on ULBI
Search ULTRALIFE CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.